Vienna, Austria – 24. April 2024 Lexogen, a leading company in transcriptomics and Next-Generation Sequencing (NGS) announces the release of RiboCop rRNA Depletion for Plants, a solution that efficiently removes unwanted ribosomal
Celebrating a Decade of QuantSeq: Unveiling the Stories Behind Our Flagship Product In the spirit of commemorating the remarkable journey of QuantSeq, Lexogen proudly presents exclusive behind-the-scenes interviews with key
When it comes to choosing a technology provider, technical support is a critical factor to consider. Whether you are a new user or an experienced one, technical issues are bound
The best ideas don’t alwayscome from outside the box Sometimes they are the box! Introducing Lexogen New Packaging with Modular Design Better for the planet 100% biodegradable100% recyclable Smaller Box
Make your short film a Winner with Lexogen 15th Anniversary! Join our Short Film Competition (open to all*)and win great prizes up to 2000 € * disclaimer related to the
Through the continued threat of COVID-19, the need for reliable methods to detect and trace viral variants is constantly increasing. Surveillance monitoring of the SARS-CoV-2 genome is required to identify
Lexogen now offers CORALL mRNA-Seq bundles including poly(A) selection providing a convenient complete workflow solution for mRNA-Seq library preparation. Features and Benefits CORALL mRNA-Seq features an easy all-in-one workflow from
In 2020, the molecule RNA (ribonucleic acid) has moved into the center of worldwide attention with the COVID 19 pandemic caused by the RNA-based SARS-CoV-2 virus. RNA is highly versatile,
Mass screening is the best solution to master the pandemic, prevent lockdown and come back to normality. This strategy will always pay-off even when a vaccine will be available as
Total RNA is comprised of large amounts of undesired transcripts, such as ribosomal RNA (rRNA), which account for ~80-98 % of the total RNA sample, and globin mRNA, accounting for
Lexogen GmbH
Campus Vienna Biocenter 5
1030 Vienna, Austria
Telephone:
+43 (0) 1 345 1212
Sales support:
+43 (0) 1 345 1212-42
Technical support:
+43 (0) 1 345 1212-41
Working hours: 9:00 – 18:00 (CET)
Fax: +43 (0) 1 345 1212-99
Email: info@lexogen.com
Company number: FN 297318 h
VAT number: ATU63622048
Lexogen, Inc.
51 Autumn Pond Park
Greenland, NH 03840, US
Telephone:
+1-603-431-4300
Sales inquiries:
Pacific Northwest: +1-971-374-4707
Northwest: +1-415-726-4318
Southwest: +1-520-934-0678
North Central: +1-312-978-6413
South Central: +1-737-767-0032
Northeast: +1-609-605-3102
Southeast: +1-615-968-3325
Technical support:
+1-949-767-1631
(Working hours: 9:00 – 15:00 (EST))
+1-603-498-1666
(Working hours: 7:00 – 15:00 (CST))
Fax: +1-603-431-43-33
Email: info@lexogen.com
Lexogen Newsletter
Subscribe to our mailing list to be among the first to get updates from us!
Sign up today, and be among the first to get a glimpse of our new innovative products and services.
Copyright © 2024 Lexogen GmbH. All rights reserved | Impressum | Privacy Policy | Terms and Conditions | Whistleblowing
Product Short Description
PRICE
Product Short Description
PRICE
Product Short Description
PRICE
